Join the Hepatocellular Carcinoma group to help and get support from people like you.
Hepatocellular Carcinoma News
Related terms: Malignant Hepatoma, HCC, Liver Cancer
FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer
TUESDAY, April 15, 2025 – The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for adults with unresectable or metastatic...
FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
PRINCETON, N.J.--(BUSINESS WIRE) April 11, 2025 – Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Opdivo® (nivolumab) plus Yervoy® (...
Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease
WEDNESDAY, March 19, 2025 – For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study...
Dose-Dependent Link Seen for Alcohol, Cirrhosis, Liver Cancer in Patients With Hep B
WEDNESDAY, Jan. 29, 2025 – For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC), according to a review...
TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer
THURSDAY, Jan. 16, 2025 – For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the addition of lenvatinib and pembrolizumab is...
FDA Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Subcutaneous Injection for Use in Most Previously Approved Solid Tumor Opdivo (nivolumab) Indications
PRINCETON, N.J.--(BUSINESS WIRE) December 27, 2024 – Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) granted approval for Opdivo Qvantig (nivolumab...
PIVKA-II-Based Model IDs Liver Cancer Risk in Hep C-Related Cirrhosis
THURSDAY, Dec. 5, 2024 – Among patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by...
Model Can Predict, Stratify Liver Cancer Risk in Noncirrhotic Chronic Hep B
TUESDAY, Sept. 17, 2024 – A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with chronic hepatitis B (CHB), according to a study...
Palliative Low-Dose Radiotherapy Improves Pain in Hepatic Cancer
TUESDAY, Sept. 10, 2024 – For adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone,...
Women With Liver Cancer Less Likely Than Men to Receive Liver Transplant
MONDAY, Sept. 9, 2024 – Women with hepatocellular carcinoma (HCC) are less likely to receive a deceased-donor liver transplant (DDLT) and more likely to die while wait-listed than men, according to a...
Outcomes Similar for Neoadjuvant ICI-Based Therapy, Upfront Surgery for Liver Cancer
THURSDAY, Aug. 22, 2024 – Patients treated with neoadjuvant immune checkpoint inhibitor (ICI)-based therapy for hepatocellular carcinoma (HCC) have higher-risk disease features but achieve outcomes...
Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver Cancer
FRIDAY, Aug. 16, 2024 – For patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does not worsen outcomes, according to research...
Cholesterol Absorption Inhibitors May Cut Risk for Liver Cancer
WEDNESDAY, July 31, 2024 – The use of cholesterol absorption inhibitors is associated with a reduced risk for liver cancer, according to a study published online July 29 in Cancer. Shahriar A. ...
Can Non-Statin Cholesterol Meds Help Your Liver?
WEDNESDAY, July 31, 2024 – Prior studies have found that statin meds can help lower liver cancer risks, and new research suggests that at least one non-statin cholesterol drug can do the same. A...
New Tool Could Spot Liver Cancer Early, Upping Survival
WEDNESDAY, June 19, 2024 – A new AI-driven blood test could improve detection of liver cancer, which is one of the most fatal cancers because early diagnosis is difficult. The test looks for “fusion ...